The GABA a agonist muscimol enhances locomotor activity, but does not alter the behavioural effects of CRH in juvenile spring chinook salmon (Oncorhynchus tshawytscha)†

Abstract

The present study investigated the effects of manipulating the GABAergic system on locomotor activity in juvenile spring chinook salmon, Oncorhynchus tshawytscha. In addition, we evaluated whether the GABAergic system is important for mediating the behavioural effects of corticotropin-releasing hormone (CRH). An intracerebroventricular (ICV) injection of the GABAa agonist muscimol caused an acute and dose dependent increase in locomotor activity in juvenile spring chinook salmon. ICV injections of the GABAa antagonist bicuculline prevented the increase in activity when administered concurrently with muscimol. The GABAb agonist baclofen had no effect on locomotor activity in this study. Furthermore, we found no evidence that the locomotor response to exogenous CRH was altered by the concurrent administration of muscimol or bicuculline. These results provide evidence to support the hypothesis that endogenous GABA within the central nervous system is involved in the control of locomotor activity in fish. The data also suggest that there is no interaction between the GABAergic system and CRH with regards to the control of locomotor activity in this species.